OPEXUS + Casepoint Partners with Cotiviti for Enhanced Legal Management
WASHINGTON, May 5, 2025 — Cotiviti, a leader in healthcare analytics, has entered into a multi-year contract with OPEXUS + Casepoint to implement an innovative legal hold management solution aimed at streamlining internal investigations and litigation processes. This collaboration will deploy Casepoint’s comprehensive platform, known for its secure, unified management capabilities.
As Cotiviti continues to expand its offerings in payment accuracy and data analytics, the need for a robust legal hold system became apparent. "We required a consolidated platform to manage legal matters efficiently," stated Brett Magun, General Counsel at Cotiviti. “After evaluating top solutions in the market, Casepoint stood out as the best choice.”
Chris Kruse, Chief Revenue Officer at OPEXUS + Casepoint, expressed excitement over the partnership, highlighting the alignment of both companies’ visions for user-friendly technology. “Our collaboration will enhance Cotiviti’s operational efficiency by reducing legal risks through advanced features such as automation and AI-driven templates," he noted.
The Casepoint platform is recognized for its impressive history with large enterprises, ease of use, and integrated eDiscovery features, making it an optimal fit for Cotiviti. The automated preservation of documents and the straightforward handling of collected data will greatly enhance compliance efforts.
OPEXUS + Casepoint combines government process management and data discovery expertise to provide technology that addresses today’s compliance challenges. This merger, finalized in 2025, aims to deliver sophisticated yet accessible solutions for both corporate and government clients.
For more information about Cotiviti’s healthcare technology solutions, visit www.cotiviti.com.
Media Contact:
Carolyn Depko
Plat4orm PR
Media Relations Manager
carolyn@plat4orm.com
Phone: 908-565-3709
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.